U.S. AIDS drug flawed
The week's news at a glance.
Kampala, Uganda
The National Institutes of Health admitted this week that it withheld potentially damaging results of research into an AIDS drug that the U.S. donated to Africa. In 2002, President Bush announced a $500 million program to provide African countries with stocks of nevirapine, a drug that helps prevent the transmission of HIV from mothers to babies during birth. Since then, thousands of African women have received the drug. But the NIH did not tell the White House that some of its research, particularly a study in Uganda, suggested a high level of adverse, even lethal, reactions to the drug. African doctors shrugged off the news, saying the drug had already saved thousands of lives. “What you may call a serious side effect in the U.S. is not a serious side effect in Kampala,” said Francis Mmiro, a lead doctor in the Uganda study.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
5 explosively funny cartoons about the 4th of July
Cartoons Artists take on liberty and justice for all, a terrifying firework, and more
-
Jeff in Venice: a "triumph of tackiness"?
In the Spotlight Locals protest as Bezos uses the city as a 'private amusement park' for his wedding celebrations
-
Sudoku medium: July 5, 2025
The Week's daily medium sudoku puzzle